Norges Bank’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-15,100
Closed -$462K 1325
2024
Q2
$462K Buy
+15,100
New +$462K ﹤0.01% 1884
2024
Q1
Sell
-546,375
Closed -$15.1M 1951
2023
Q4
$15.1M Buy
546,375
+12,500
+2% +$345K ﹤0.01% 1349
2023
Q3
$12M Buy
533,875
+3,800
+0.7% +$85.2K ﹤0.01% 1400
2023
Q2
$21.6M Sell
530,075
-40,376
-7% -$1.64M ﹤0.01% 1224
2023
Q1
$27.6M Sell
570,451
-73,706
-11% -$3.57M 0.01% 1119
2022
Q4
$24.6M Sell
644,157
-47,917
-7% -$1.83M 0.01% 1160
2022
Q3
$34.7M Buy
692,074
+11,146
+2% +$560K 0.01% 933
2022
Q2
$27.3M Buy
680,928
+118,112
+21% +$4.73M 0.01% 1089
2022
Q1
$21M Buy
562,816
+148,190
+36% +$5.53M ﹤0.01% 1381
2021
Q4
$16.5M Sell
414,626
-134,514
-24% -$5.36M ﹤0.01% 1568
2021
Q3
$20.4M Buy
549,140
+29,728
+6% +$1.11M ﹤0.01% 1473
2021
Q2
$22M Buy
519,412
+73,666
+17% +$3.11M ﹤0.01% 1482
2021
Q1
$21.1M Sell
445,746
-108,544
-20% -$5.14M ﹤0.01% 1516
2020
Q4
$33.8M Buy
554,290
+47,161
+9% +$2.88M 0.01% 1234
2020
Q3
$23.7M Sell
507,129
-66,754
-12% -$3.12M 0.01% 1299
2020
Q2
$29.1M Sell
573,883
-98,629
-15% -$5M 0.01% 1193
2020
Q1
$30M Buy
672,512
+13,320
+2% +$594K 0.01% 978
2019
Q4
$31.7M Buy
659,192
+24,875
+4% +$1.19M 0.01% 1225
2019
Q3
$21.5M Buy
634,317
+19,824
+3% +$670K 0.01% 1442
2019
Q2
$27.7M Buy
614,493
+506,123
+467% +$22.8M 0.01% 1280
2019
Q1
$4.08M Buy
+108,370
New +$4.08M ﹤0.01% 1957
2016
Q4
Sell
-125,458
Closed -$1.68M 2165
2016
Q3
$1.68M Buy
125,458
+90,181
+256% +$1.21M ﹤0.01% 1997
2016
Q2
$247K Sell
35,277
-75,014
-68% -$525K ﹤0.01% 2148
2016
Q1
$710K Hold
110,291
﹤0.01% 2109
2015
Q4
$3.57M Sell
110,291
-67,267
-38% -$2.18M ﹤0.01% 1935
2015
Q3
$4.74M Sell
177,558
-27,394
-13% -$731K ﹤0.01% 1856
2015
Q2
$9.87M Buy
204,952
+71,068
+53% +$3.42M ﹤0.01% 1626
2015
Q1
$8.15M Buy
+133,884
New +$8.15M ﹤0.01% 1733